Trigeminal Neuralgia Treatment Market Growth Insight: Global Industry Analysis by Size, Share, Comprehensive Analysis, Future Trends and Competitive Landscape to Forecast by 2026
SEATTLE, March 25, 2021, (PHARMIWEB) — Global Trigeminal Neuralgia Treatment Market – Insights
Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain condition that affects the trigeminal nerve. Symptoms of the condition include, mild to severe facial pain, often triggered by chewing, speaking, or brushing the teeth. The condition is associated with Lyme disease, sarcoidosis, multiple sclerosis, and collagen vascular diseases including systemic lupus erythematosus and scleroderma. The exact cause of the condition is not understood.
*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1536
Although TN can affect individuals of any age, it is highly common in people aged 50 years or above. Moreover, young adults suffering from multiple sclerosis also have high risk of developing TN. The condition is more common among women than in men. The cause of the disease is mostly idiopathic in young individuals. In adults, damage in the central nervous system is a major cause of TN. The condition is extremely rare in children.
Treatment for TN includes medications, injections, and surgery. The condition is treated on an outpatient basis, except till neurosurgical intervention is required. The disease requires customized management for each patient, based on the patient’s general condition and age. Surgery is recommended when medications lead to side-effects or are ineffective in treatment of the disease. There are three main types of surgeries: rhizotomy, stereotactic radiosurgery, and microvascular decompression.
Rhizotomy is an outpatient procedure performed under general anesthesia. Idiopathic trigeminal neuralgia, for which cause is unknown, is mostly treated with a single anticonvulsant medication such as carbamazepine. Carbamazepine, oxcarbazepine, gabapentin, lamotrigine or baclofen are some drugs used in treatment of TN.
Exclusive offer!!! Purchase the report at a discounted rate!!!
Apply Promo Code “CMIFIRST1000” and Get Up to 30% Discount
Quick Buy – Trigeminal Neuralgia Treatment Market Research Report: https://bit.ly/2P4CWUq
Global Trigeminal Neuralgia Treatment Market: Drivers
High prevalence of TN is expected to boost growth of the global trigeminal neuralgia treatment market over the forecast period. For instance, according to the National Institute of Neurological Disorders and Stroke (NINDS), the number of new cases for TN is around 12 per 100,000, annually. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015.
Moreover, increasing initiatives to offer guidelines for the management of trigeminal neuralgia is also expected to aid in growth of the market. For instance, the European Federation of Neurological Societies and the American Academy of Neurology launched a combined task force to prepare general guidelines for the management of trigeminal neuralgia.
Global Trigeminal Neuralgia Treatment Market: Restraints
TN treatment can lead to various side effects such as amnesia, nausea, drowsiness, dizziness, and unsteadiness, which is expected to hinder growth of the market. Moreover, TN drugs lose their effectiveness with time, requiring greater number of medications or higher doses taken together. Continued delays in diagnosis and a lack of psychological support are other factors that limit growth of the market.
Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1536
Global Trigeminal Neuralgia Treatment Market: Regional Analysis
North America is expected to account for the largest market share in the global trigeminal neuralgia treatment market over the forecast period. This is attributed to increasing awareness regarding TN. For instance, The Facial Pain Research Foundation and Intl Trigeminal Neuralgia and Me organize the International Trigeminal Neuralgia Awareness Day on October 7 every year.
High incidence of TN is expected to boost growth of the market in Asia Pacific. For instance, according to a study published by Omics International, around 4,458,090 people, accounting for 2.6% of the total population is suffering from TN in China.
Global Trigeminal Neuralgia Treatment Market: Competitive Landscape
Major players operating in the global trigeminal neuralgia treatment market include Allergan Plc, Merz Pharma GmbH & Co., Biogen, Inc., Merz Pharma GmbH & Co., Abbott Laboratories, Trigemina Inc., Pfizer Inc., Novartis, and GlaxoSmithKline Plc.
Major players in the market are focused on R&D in treatment of TN. For instance, NanoVibronix’s PainShield transmits slow release ultrasound to deliver fast pain relief for nerve and soft tissue damage. It is extremely effective and provides TN acute pain relief and treatment.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/trigeminal-neuralgia-treatment-market-1536
Global Trigeminal Neuralgia Treatment Market Taxonomy
- Drug Type
- Stereotactic Radiosurgery
- Microvascular Decompression
Table of Content
Global Trigeminal Neuralgia Treatment Market Research Report
Section 1: Global Trigeminal Neuralgia Treatment Industry Overview
Section 2: Global Economic Impact on Trigeminal Neuralgia Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Trigeminal Neuralgia Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Trigeminal Neuralgia Treatment Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire